What test measures hepatitis B surface antibody (anti-HBs) titer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis B Surface Antibody (Anti-HBs) Titer Testing

Order a quantitative anti-HBs test using enzyme-linked immunosorbent assay (ELISA) or equivalent immunoassay method to measure the hepatitis B surface antibody titer. 1

Specific Test Methodology

  • The quantitative anti-HBs test should be performed using methods such as ELISA that can detect and quantify antibody levels in mIU/mL. 1
  • The test must be capable of detecting the protective concentration threshold of ≥10 mIU/mL, which is the established standard for immunity according to the CDC and ACIP. 2, 1
  • Quantitative methods are superior to qualitative tests because they provide the exact antibody concentration, allowing precise determination of protective immunity versus inadequate response. 1

Optimal Timing for Testing

  • Testing should be performed 1-2 months after completion of the hepatitis B vaccination series to accurately assess immune response and allow adequate time for antibody development. 3, 1
  • If hepatitis B immune globulin (HBIG) was administered, wait 3-4 months before testing anti-HBs, as passively acquired antibodies from HBIG can interfere with accurate assessment of vaccine response. 3

Interpretation of Results

  • Anti-HBs ≥10 mIU/mL indicates protective immunity against HBV infection and is the universally accepted threshold. 2, 1, 4
  • Anti-HBs levels of 1-9 mIU/mL are considered inadequate for protection, though these individuals respond better to revaccination compared to those with undetectable antibodies. 2
  • Anti-HBs <10 mIU/mL after vaccination indicates lack of protective immunity and necessitates revaccination. 1

Distinguishing Vaccination from Natural Infection

  • Order a complete serologic panel including HBsAg, anti-HBs, and total anti-HBc if you need to determine whether immunity is from vaccination versus resolved natural infection. 1
  • Anti-HBs positive + anti-HBc negative = immunity from vaccination only. 3, 1, 4
  • Anti-HBs positive + anti-HBc positive = immunity from resolved natural HBV infection. 3, 1

Special Testing Considerations

  • Healthcare workers require mandatory post-vaccination anti-HBs testing 1-2 months after completing the vaccine series to ensure protection before potential occupational exposures. 1
  • Hemodialysis patients need annual anti-HBs testing due to accelerated antibody waning in this population. 1
  • Immunocompromised patients (HIV-infected, chemotherapy recipients, transplant patients) may require annual testing to monitor anti-HBs concentrations. 1

Common Pitfalls to Avoid

  • Do not test anti-HBs too early after vaccination (before 1-2 months), as antibodies may not have reached peak levels yet. 3, 1
  • Avoid testing within 3-4 months of HBIG administration, as this will detect passively acquired antibodies rather than vaccine-induced immunity. 3
  • Do not use qualitative (positive/negative only) tests when quantitative results are needed to assess adequacy of immune response. 1
  • Be aware that different assay methods may yield varying results, with some methods potentially underestimating anti-HBs titers compared to others. 5

References

Guideline

Assessing Hepatitis B Immunity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Low Hepatitis B Surface Antibody Interpretation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatitis B Immunity and Serologic Test Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.